FDA-Drug2026-06-24Class IIPROCESSING DEFECT

Cura Hongos antifungal cream recalled for manufacturing deficiencies

OTHERNationwide distributionDrugs

What this means

Dabur India Limited's Cura Hongos antifungal cream (clotrimazole 1%, 2oz tubes) was found to have manufacturing deficiencies during an FDA inspection. The affected product (Lot #0003) does not meet U.S. manufacturing standards. No injuries have been reported.

  • Check your medicine cabinet for Cura Hongos clotrimazole cream, 2oz tubes.
  • If you have Lot #0003, stop using it.
  • Return the product to where you purchased it, or contact Pharmadel LLC for instructions.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

CGMP Deviations; deficiencies observed during FDA inspection

Intended for
Adults
Illnesses reported
None reported
Sold states
US Nationwide.
Affected count
84 tubes
Manufactured in
225 - 4 - 1 Saily Village, Survey No, Dadra And Nagar Haveli, India
Products
Cura Hongos, Crema Antifungica, Clotrimazole 1%, 2oz (57g) tubes, Dist by/por: Pharmadel LLC, New Castle, DE 19720, Made in India, UPC 8 52924 00683 1.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0634-2026

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.